Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00556959 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: high dose clonidine HCl sustained release
DRUG: low dose clonidine HCl sustained release
DRUG: placebo

Sponsor

Addrenex Pharmaceuticals, Inc.